Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers
Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have...
Saved in:
| Published in | Journal of cellular physiology Vol. 235; no. 3; pp. 1962 - 1972 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Wiley Subscription Services, Inc
01.03.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have multiple applications in different branches of science. In recent years, NPs have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging. A wide range of nanomaterials based on organic, inorganic, lipid, or glycan compounds, as well as on synthetic polymers has been utilized for the development and improvement of new cancer therapeutics. In this study, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy.
In recent years, nanoparticles (NPs) have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging.In this review, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy. |
|---|---|
| AbstractList | Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have multiple applications in different branches of science. In recent years, NPs have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging. A wide range of nanomaterials based on organic, inorganic, lipid, or glycan compounds, as well as on synthetic polymers has been utilized for the development and improvement of new cancer therapeutics. In this study, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy. Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have multiple applications in different branches of science. In recent years, NPs have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging. A wide range of nanomaterials based on organic, inorganic, lipid, or glycan compounds, as well as on synthetic polymers has been utilized for the development and improvement of new cancer therapeutics. In this study, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy.Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have multiple applications in different branches of science. In recent years, NPs have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging. A wide range of nanomaterials based on organic, inorganic, lipid, or glycan compounds, as well as on synthetic polymers has been utilized for the development and improvement of new cancer therapeutics. In this study, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy. Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multifunctionality. Nowadays, nanoparticles (NPs) have multiple applications in different branches of science. In recent years, NPs have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging. A wide range of nanomaterials based on organic, inorganic, lipid, or glycan compounds, as well as on synthetic polymers has been utilized for the development and improvement of new cancer therapeutics. In this study, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy. In recent years, nanoparticles (NPs) have repetitively been reported to play a significant role in modern medicine. They have been analyzed for different clinical applications, such as drug carriers, gene delivery to tumors, and contrast agents in imaging.In this review, we discuss the role of NPs in treating cancer among different drug delivery methods for cancer therapy. |
| Author | Fotouhi, Ali Baghbanzhadeh, Amir Asadi, Milad Aghebati‐Maleki, Leili Aghebati‐Maleki, Ali Yousefi, Mehdi Dolati, Sanam Ahmadi, Majid |
| Author_xml | – sequence: 1 givenname: Ali surname: Aghebati‐Maleki fullname: Aghebati‐Maleki, Ali organization: Tabriz University of Medical Sciences – sequence: 2 givenname: Sanam orcidid: 0000-0002-6257-5411 surname: Dolati fullname: Dolati, Sanam organization: Tabriz University of Medical Sciences – sequence: 3 givenname: Majid orcidid: 0000-0001-9845-9140 surname: Ahmadi fullname: Ahmadi, Majid organization: Tabriz University of Medical Sciences – sequence: 4 givenname: Amir surname: Baghbanzhadeh fullname: Baghbanzhadeh, Amir organization: Tabriz University of Medical Sciences – sequence: 5 givenname: Milad surname: Asadi fullname: Asadi, Milad organization: Tabriz University of Medical Sciences – sequence: 6 givenname: Ali surname: Fotouhi fullname: Fotouhi, Ali organization: Shahid Beheshti University of Medical Sciences – sequence: 7 givenname: Mehdi orcidid: 0000-0002-1144-098X surname: Yousefi fullname: Yousefi, Mehdi email: yousefime@tbzmed.ac.ir organization: Tabriz University of Medical Sciences – sequence: 8 givenname: Leili orcidid: 0000-0002-0044-5961 surname: Aghebati‐Maleki fullname: Aghebati‐Maleki, Leili email: aghebatil@tbzmed.ac.ir organization: Tabriz University of Medical Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31441032$$D View this record in MEDLINE/PubMed |
| BookMark | eNp10U1PGzEQBmALUUGgPfQPoJV6oYcFj71Z1r2hqJ9CLYf2bI29s8JhYy-2Q5V_X4eEQ1F78sHP-8qeOWGHPnhi7C3wC-BcXC7tdCEUiPaAzYCrq7pp5-KQzcod1GrewDE7SWnJOVdKyiN2LKFpgEsxY_ff0YcJY3Z2pFSh7yuL3lKs8h1FnDYfqluKaSKb3WMBQ4gVTtPoLGYXfBWGyv_V4Pw2WeVImFfk81bsGtNr9mrAMdGb_XnKfn36-HPxpb758fnr4vqmtg2otm5V3yhqaUDF0VpjRG84SGmhtw2CHbrWdNgZY2TPifOuBYPlq4RkBUAvT9n5rneK4WFNKeuVS5bGET2FddJCCnElhZyLQt-9oMuwjr68bqtAdrztoKizvVqbFfV6im6FcaOfx1jA5Q7YGFKKNGjr8tOAckQ3auB6uyhdFqWfFlUS718knkv_Zfftv91Im_9D_W1xu0v8AcMBoy0 |
| CitedBy_id | crossref_primary_10_3233_MGC_210164 crossref_primary_10_1007_s12668_024_01647_y crossref_primary_10_3390_chemengineering5040069 crossref_primary_10_1016_j_carres_2024_109220 crossref_primary_10_3390_pharmaceutics15010280 crossref_primary_10_1049_nbt2_12065 crossref_primary_10_1016_j_cej_2024_155593 crossref_primary_10_1080_07391102_2022_2160815 crossref_primary_10_3389_fonc_2021_594917 crossref_primary_10_1016_j_jddst_2021_102530 crossref_primary_10_1016_j_jddst_2023_104835 crossref_primary_10_1016_j_tice_2022_101755 crossref_primary_10_1002_cbin_11465 crossref_primary_10_1080_00914037_2022_2097680 crossref_primary_10_1080_10717544_2021_1917728 crossref_primary_10_1007_s10098_022_02329_7 crossref_primary_10_1021_acsabm_4c01527 crossref_primary_10_1038_s41598_023_38230_6 crossref_primary_10_1080_00914037_2023_2277235 crossref_primary_10_1002_advs_202102678 crossref_primary_10_1007_s10971_023_06251_2 crossref_primary_10_1142_S1793984423300042 crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2023046674 crossref_primary_10_1007_s12668_023_01196_w crossref_primary_10_1360_SSV_2023_0003 crossref_primary_10_2147_IJN_S490661 crossref_primary_10_2174_1567201819666220426092538 crossref_primary_10_1039_D3RA00768E crossref_primary_10_2147_IJN_S461300 crossref_primary_10_1016_j_bbiosy_2022_100047 crossref_primary_10_1140_epjp_s13360_022_03607_5 crossref_primary_10_32604_or_2024_053069 crossref_primary_10_1016_j_jddst_2023_104827 crossref_primary_10_1039_D2TB01858F crossref_primary_10_1016_j_ijpharm_2022_121761 crossref_primary_10_1155_2024_9914079 crossref_primary_10_1186_s12951_022_01746_6 crossref_primary_10_14356_kona_2023002 crossref_primary_10_1016_j_jddst_2023_104708 crossref_primary_10_1007_s12011_022_03458_2 crossref_primary_10_1007_s10529_024_03491_2 crossref_primary_10_1142_S0217979225500559 crossref_primary_10_1155_2022_5041399 crossref_primary_10_2147_IJN_S446919 crossref_primary_10_2147_IJN_S317626 crossref_primary_10_1016_j_envres_2023_116951 crossref_primary_10_3389_fphar_2024_1303412 crossref_primary_10_1016_j_ejmech_2021_113292 crossref_primary_10_1007_s12672_023_00733_z crossref_primary_10_1088_1361_6528_ac21ef crossref_primary_10_1177_15347354241242094 crossref_primary_10_1002_vjch_202300025 crossref_primary_10_1007_s40843_020_1627_4 crossref_primary_10_1007_s40846_024_00911_6 crossref_primary_10_3390_polym15041025 crossref_primary_10_1021_acsomega_3c09987 crossref_primary_10_3389_fbioe_2024_1382085 crossref_primary_10_1615_OncoTherap_2022044575 crossref_primary_10_3389_fgene_2021_728250 crossref_primary_10_1039_D3TB01317K crossref_primary_10_1016_j_molliq_2025_127403 crossref_primary_10_34133_bmef_0025 crossref_primary_10_1039_D3BM00271C crossref_primary_10_51847_sPFPlDPSVl crossref_primary_10_3390_pharmaceutics14091965 crossref_primary_10_1016_j_yexcr_2021_112633 crossref_primary_10_1080_01635581_2021_1876889 crossref_primary_10_3389_fmolb_2022_1044063 crossref_primary_10_3390_nano12183166 crossref_primary_10_1016_j_nantod_2023_101891 crossref_primary_10_1186_s12645_021_00083_x crossref_primary_10_1038_s41598_024_55900_1 crossref_primary_10_37349_etat_2024_00272 crossref_primary_10_1016_j_jsamd_2025_100877 crossref_primary_10_1002_slct_202103495 crossref_primary_10_3390_nano11051108 crossref_primary_10_1049_mna2_12093 crossref_primary_10_3390_nano12010175 crossref_primary_10_1016_j_surfin_2024_104779 crossref_primary_10_1080_26895293_2022_2103592 crossref_primary_10_3390_pharmaceutics15051346 crossref_primary_10_1021_acsanm_2c04933 crossref_primary_10_3390_jfb14010012 crossref_primary_10_3390_ma15062086 crossref_primary_10_1016_j_nano_2024_102744 crossref_primary_10_1002_jemt_24719 crossref_primary_10_1016_j_colsurfb_2022_112350 crossref_primary_10_3390_pharmaceutics13121993 crossref_primary_10_1007_s44174_025_00295_4 crossref_primary_10_2174_1568009622666220609115109 crossref_primary_10_3390_nano10071309 crossref_primary_10_2147_IJN_S442768 crossref_primary_10_1016_j_matpr_2021_02_232 crossref_primary_10_1039_D3NA00462G crossref_primary_10_1134_S0036024423130095 crossref_primary_10_1016_j_biochi_2024_07_017 crossref_primary_10_18097_pbmc20236906409 crossref_primary_10_3390_nano14242018 crossref_primary_10_36790_epistemus_v16i33_223 crossref_primary_10_1016_j_molliq_2021_115417 crossref_primary_10_3390_cancers14102456 crossref_primary_10_3390_ijms222212100 crossref_primary_10_1016_j_jddst_2023_104500 crossref_primary_10_1007_s11356_022_23018_4 crossref_primary_10_3390_app10155194 crossref_primary_10_1007_s13538_024_01591_y crossref_primary_10_1016_j_mtbio_2023_100633 crossref_primary_10_1186_s12951_024_02585_3 crossref_primary_10_1016_j_heliyon_2023_e22758 crossref_primary_10_1016_j_ijpharm_2025_125381 crossref_primary_10_1016_j_prp_2023_154684 crossref_primary_10_3389_fchem_2025_1521089 crossref_primary_10_3390_nano12101763 crossref_primary_10_2147_IJN_S368814 crossref_primary_10_1038_s41598_024_51848_4 crossref_primary_10_1016_j_phymed_2024_155554 crossref_primary_10_1007_s12648_024_03181_9 crossref_primary_10_2174_1573413719666230503144904 crossref_primary_10_1016_j_biopha_2022_113305 crossref_primary_10_1039_D1CS01074C crossref_primary_10_1080_02656736_2020_1810333 crossref_primary_10_3390_biomedicines10010077 crossref_primary_10_1097_CAD_0000000000001532 crossref_primary_10_2174_1871520621666210708123750 crossref_primary_10_1142_S1793984423300029 crossref_primary_10_2147_IJN_S401570 crossref_primary_10_1016_j_nanoso_2025_101453 crossref_primary_10_1016_j_pmatsci_2023_101209 crossref_primary_10_1142_S179398442141004X crossref_primary_10_3389_fdmed_2024_1482166 crossref_primary_10_1007_s10527_024_10376_1 crossref_primary_10_1016_j_chest_2019_11_036 crossref_primary_10_1038_s41380_022_01527_5 crossref_primary_10_3390_pharmaceutics16101327 crossref_primary_10_1007_s13205_022_03372_3 crossref_primary_10_1007_s13204_020_01653_y crossref_primary_10_3390_ijms222011298 crossref_primary_10_1080_10717544_2022_2144541 crossref_primary_10_1016_j_rineng_2022_100731 crossref_primary_10_3390_pharmaceutics16040473 crossref_primary_10_18231_j_jdpo_2024_017 crossref_primary_10_1007_s11051_021_05190_9 crossref_primary_10_1039_D0NJ05227B crossref_primary_10_1016_j_biopha_2023_114710 crossref_primary_10_1007_s00210_024_03082_y crossref_primary_10_1016_j_ijpharm_2023_122779 crossref_primary_10_1088_1361_6528_ac1098 crossref_primary_10_1080_17425247_2022_2051477 crossref_primary_10_1186_s12645_023_00174_x crossref_primary_10_3389_fonc_2022_809304 crossref_primary_10_61186_mlj_17_6_16 crossref_primary_10_1016_j_biopha_2024_117161 crossref_primary_10_1007_s12247_021_09551_8 crossref_primary_10_1021_acs_langmuir_1c01821 crossref_primary_10_3390_ijms25021001 crossref_primary_10_1016_j_jece_2022_108802 crossref_primary_10_1021_acsbiomaterials_3c00745 crossref_primary_10_1080_10837450_2024_2436190 crossref_primary_10_1016_j_compbiomed_2024_109235 crossref_primary_10_1080_1061186X_2021_2016773 crossref_primary_10_37349_eds_2025_100889 crossref_primary_10_3390_pharmaceutics14050917 crossref_primary_10_3390_biomedicines11051292 crossref_primary_10_1557_s43578_022_00583_5 crossref_primary_10_3390_ijms22179587 crossref_primary_10_1002_ardp_202000137 crossref_primary_10_1002_jcp_29789 crossref_primary_10_1039_D3SM01190A crossref_primary_10_19053_01217488_v15_n2_2024_16015 crossref_primary_10_1016_j_ijbiomac_2020_09_166 crossref_primary_10_1093_jambio_lxac044 crossref_primary_10_2147_IJN_S378074 crossref_primary_10_1016_j_jddst_2024_105375 crossref_primary_10_1016_j_envres_2023_117795 crossref_primary_10_3389_fimmu_2020_575816 crossref_primary_10_3390_pharmaceutics13081321 crossref_primary_10_1016_j_biotno_2023_12_002 crossref_primary_10_1186_s12935_021_01836_9 crossref_primary_10_1080_1120009X_2024_2308980 crossref_primary_10_1016_j_bioadv_2022_213184 crossref_primary_10_1186_s12951_024_02611_4 crossref_primary_10_1016_j_jddst_2024_105819 crossref_primary_10_1557_s43577_021_00132_1 crossref_primary_10_1016_j_colsurfb_2023_113532 crossref_primary_10_3389_fimmu_2022_1035997 crossref_primary_10_1016_j_pdpdt_2021_102686 crossref_primary_10_3389_fcvm_2022_986570 crossref_primary_10_3389_fnume_2023_1184309 crossref_primary_10_2174_1568009621666210525152802 crossref_primary_10_1007_s10876_021_02211_4 crossref_primary_10_1016_j_jconrel_2021_08_027 crossref_primary_10_1016_j_jddst_2023_105184 crossref_primary_10_1021_acsomega_2c07840 crossref_primary_10_1007_s00210_024_02945_8 crossref_primary_10_1002_wnan_2013 crossref_primary_10_1007_s11051_020_05052_w crossref_primary_10_1080_24701556_2021_2025074 crossref_primary_10_22159_ijap_2024v16i5_51647 crossref_primary_10_3390_jcs8010028 crossref_primary_10_1088_1361_6528_ab91f6 crossref_primary_10_3390_ma14112968 crossref_primary_10_1049_2024_3786627 crossref_primary_10_1088_1742_6596_1762_1_012001 crossref_primary_10_1177_15593258211019880 crossref_primary_10_3389_fcell_2024_1514399 crossref_primary_10_4236_ojrm_2025_141001 crossref_primary_10_1007_s12668_024_01385_1 crossref_primary_10_1016_j_omtn_2023_03_021 crossref_primary_10_1007_s13399_024_05982_8 crossref_primary_10_3389_fbioe_2024_1410017 crossref_primary_10_3390_cancers14061455 crossref_primary_10_2174_0113894501294136240610061328 crossref_primary_10_1016_j_mtchem_2022_101182 crossref_primary_10_1016_j_nxmate_2024_100394 crossref_primary_10_2174_1574892817666221005094423 crossref_primary_10_1016_j_inoche_2023_111494 crossref_primary_10_5306_wjco_v13_i7_553 crossref_primary_10_1016_j_jece_2023_110147 crossref_primary_10_1002_cnma_202000539 crossref_primary_10_2174_1874467213666200730114943 crossref_primary_10_1016_j_ijpharm_2022_122439 crossref_primary_10_2147_IJN_S287415 crossref_primary_10_1021_acsanm_1c03487 crossref_primary_10_3390_nano10081592 crossref_primary_10_3390_pharmaceutics15071958 crossref_primary_10_53941_ijddp_0201010 crossref_primary_10_1016_j_ijbiomac_2022_09_271 crossref_primary_10_1007_s10404_024_02735_x crossref_primary_10_1016_j_jtemb_2024_127526 crossref_primary_10_3390_ijms241612827 crossref_primary_10_1039_D1NR07725B crossref_primary_10_1016_j_ijbiomac_2024_136096 crossref_primary_10_2174_0118715206293653240322041047 crossref_primary_10_1039_D1BM01663F crossref_primary_10_1080_00914037_2021_1941957 crossref_primary_10_2174_03666220921100058 crossref_primary_10_1007_s13346_023_01501_w crossref_primary_10_1016_j_jddst_2020_101883 crossref_primary_10_3390_pharmaceutics15020607 crossref_primary_10_1016_j_inoche_2024_112819 crossref_primary_10_1016_j_ijpharm_2024_124023 crossref_primary_10_1016_j_lfs_2021_119667 crossref_primary_10_1007_s44174_025_00276_7 crossref_primary_10_1021_acsabm_1c00591 crossref_primary_10_2147_IJN_S500978 crossref_primary_10_1016_j_jddst_2023_104357 crossref_primary_10_3390_pharmaceutics17030277 crossref_primary_10_1080_00914037_2023_2230340 crossref_primary_10_1007_s00289_022_04119_z crossref_primary_10_1016_j_jddst_2023_105326 crossref_primary_10_3390_ijms241310910 crossref_primary_10_1007_s13204_022_02669_2 crossref_primary_10_1051_matecconf_202440501001 crossref_primary_10_1016_j_pmatsci_2023_101190 crossref_primary_10_1016_j_abst_2024_06_003 crossref_primary_10_1016_j_envres_2021_111375 crossref_primary_10_1007_s10555_023_10158_3 crossref_primary_10_1039_D3RE00417A crossref_primary_10_1016_j_ijbiomac_2024_136512 crossref_primary_10_1080_14712598_2020_1738377 crossref_primary_10_1007_s13399_023_03873_y crossref_primary_10_1016_j_bioadv_2022_213013 crossref_primary_10_1021_acssuschemeng_1c03409 crossref_primary_10_2174_1573394718666220428105301 crossref_primary_10_1016_j_sajb_2024_07_026 crossref_primary_10_1088_2043_6262_adb55c crossref_primary_10_3390_cancers12092425 crossref_primary_10_1038_s41420_023_01778_3 crossref_primary_10_1080_17518253_2023_2169591 crossref_primary_10_1016_j_ijbiomac_2024_138495 crossref_primary_10_3390_cancers14184462 crossref_primary_10_1016_j_cpcardiol_2024_102466 crossref_primary_10_1016_j_ijpharm_2021_121134 crossref_primary_10_2139_ssrn_4200065 crossref_primary_10_1080_2314808X_2023_2301281 crossref_primary_10_1016_j_prp_2024_155408 crossref_primary_10_3390_nano14100827 crossref_primary_10_1042_BSR20230504 crossref_primary_10_3390_cancers14215363 crossref_primary_10_1016_j_mtcomm_2023_105318 crossref_primary_10_1039_D3TB01175E crossref_primary_10_1080_20415990_2024_2395249 crossref_primary_10_3390_ijms24065439 crossref_primary_10_1007_s12640_020_00283_0 crossref_primary_10_1016_j_jinorgbio_2021_111540 |
| Cites_doi | 10.2174/1389557517666170512095151 10.2174/138920012798356899 10.1038/s41392‐017‐0004‐3 10.1002/cmmi.420 10.1016/j.copbio.2004.11.003 10.3390/pharmaceutics9020012 10.1039/C6TB01095D 10.1016/j.ijpharm.2004.12.010 10.1038/nmat1390 10.1039/c7nr07450f 10.3390/molecules23040938 10.3389/fphar.2017.00374 10.1007/s10856‐009‐3807‐0 10.1038/clpt.2008.296 10.1021/acs.jafc.8b01052 10.1016/j.yexmp.2008.12.004 10.1126/science.1242477 10.1056/nejm200103153441101 10.1055/s-1978-24702 10.5402/2012/571394 10.4103/0975‐7406.130965 10.3389/fphar.2018.00790 10.2217/nnm.12.185 10.1016/j.bbamem.2009.06.022 10.1038/nbt1003 10.15226/2374‐6866/1/2/00109 10.1038/nbt929 10.1007/s11060‐005‐9059‐z 10.1177/117739280700200002 10.1007/978‐1‐60327‐198‐1_1 10.1007/978-0-387-30428-1_15 10.1021/mp1001944 10.2174/1389200217666160619191853 10.1016/j.drudis.2011.10.028 10.1007/s00430‐009‐0116‐7 10.2147/IJN.S596 10.1517/17425247.2014.924501 10.1016/j.nano.2014.11.003 10.1038/nbt0202‐155 10.2741/e102 10.1016/j.nbd.2009.07.028 10.1038/nm1101‐1241 10.1038/nrd2591 10.1016/j.ijpharm.2018.12.080 10.1289/ehp.8284 10.1016/j.arabjc.2017.05.011 10.1146/annurev.bioeng.9.060906.152025 10.1016/S1369‐7021(10)70142‐5 10.2147/ijn.s129300 10.1016/j.nantod.2016.07.002 10.4103/2230‐973x.96920 10.1016/j.ijpharm.2018.10.011 10.1016/j.tibtech.2016.08.011 10.3390/ma3021420 10.1021/acs.biomac.6b01604 10.1016/j.ijbiomac.2016.12.055 10.1208/s12249‐014‐0113‐z 10.1021/nl8029114 10.1021/ac034672u 10.1093/annonc/mdh097 10.1038/nmeth791 10.3390/app8020172 10.1021/nn900761s 10.1021/nn900002m 10.1016/j.jconrel.2015.10.006 10.1038/nbt764 10.1021/nn101427t 10.1021/cm2031569 10.1038/sj.bjc.6602204 10.1158/1078‐0432.ccr‐06‐0946 10.1038/nrc.2016.108 10.4103/0250‐474x.57282 10.17795/ijcp‐3966 10.1002/wnan.72 10.1016/j.bjbas.2017.03.004 10.1158/0008‐5472.can‐10‐1022 10.2147/ijn.s111594 10.1016/s0140‐6736(05)66544‐0 10.1186/bcr432 10.1021/acsami.8b04962 10.1002/1097-0142(20010501)91:9<1826::AID-CNCR1203>3.0.CO;2-J 10.1002/anie.200905126 10.1021/acsbiomaterials.7b00181 10.1140/epje/i2016‐16059‐8 10.1080/1061186x.2018.1527337 10.2147/ijn.s46900 10.1007/s11060‐006‐9195‐0 10.1039/b107318b 10.2174/1389200217666160728152939 10.3389/fmolb.2017.00052 10.1200/jco.2002.20.3.719 10.1200/jco.2001.19.5.1444 |
| ContentType | Journal Article |
| Copyright | 2019 Wiley Periodicals, Inc. |
| Copyright_xml | – notice: 2019 Wiley Periodicals, Inc. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 8FD C1K FR3 K9. P64 RC3 7X8 |
| DOI | 10.1002/jcp.29126 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database Toxicology Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Biology |
| EISSN | 1097-4652 |
| EndPage | 1972 |
| ExternalDocumentID | 31441032 10_1002_jcp_29126 JCP29126 |
| Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Tabriz University of Medical Sciences, Tabriz, Iran funderid: 63659 |
| GroupedDBID | --- -DZ -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 9M8 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDPE ABEFU ABEML ABIJN ABJNI ABPPZ ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BQCPF BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ H~9 IH2 IX1 J0M JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M56 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MVM MXFUL MXSTM N04 N05 N9A NEJ NF~ NNB O66 O9- OHT OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RWR RX1 RYL S10 SAMSI SUPJJ SV3 TN5 TWZ UB1 UPT V2E V8K VQP W8V W99 WBKPD WH7 WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WXSBR WYB WYISQ X7M XG1 XJT XOL XPP XSW XV2 Y6R YQT YZZ ZGI ZXP ZZTAW ~IA ~WT AAYXX ADXHL AETEA AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7TK 7U7 8FD C1K FR3 K9. P64 RC3 7X8 |
| ID | FETCH-LOGICAL-c4196-69d49e6efa90accbb2db0133c1dc4a1cf86b8a8bbb3d0e00861ba002eaec211d3 |
| IEDL.DBID | DR2 |
| ISSN | 0021-9541 1097-4652 |
| IngestDate | Fri Jul 11 11:29:17 EDT 2025 Fri Jul 25 22:27:09 EDT 2025 Mon Jul 21 05:58:35 EDT 2025 Tue Jul 01 01:32:05 EDT 2025 Thu Apr 24 23:07:55 EDT 2025 Wed Jan 22 16:36:18 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | cancer therapy therapeutics nanoparticles drug delivery |
| Language | English |
| License | 2019 Wiley Periodicals, Inc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4196-69d49e6efa90accbb2db0133c1dc4a1cf86b8a8bbb3d0e00861ba002eaec211d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-9845-9140 0000-0002-6257-5411 0000-0002-0044-5961 0000-0002-1144-098X |
| PMID | 31441032 |
| PQID | 2321380681 |
| PQPubID | 1006363 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_2322732352 proquest_journals_2321380681 pubmed_primary_31441032 crossref_citationtrail_10_1002_jcp_29126 crossref_primary_10_1002_jcp_29126 wiley_primary_10_1002_jcp_29126_JCP29126 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | March 2020 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 03 year: 2020 text: March 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | Journal of cellular physiology |
| PublicationTitleAlternate | J Cell Physiol |
| PublicationYear | 2020 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | e_1_2_15_1_30_1 e_1_2_15_1_76_1 e_1_2_15_1_97_1 Laurent S. (e_1_2_15_1_51_1) 2011; 2 e_1_2_15_1_34_1 e_1_2_15_1_55_1 e_1_2_15_1_72_1 e_1_2_15_1_93_1 Grumezescu A. M. (e_1_2_15_1_31_1) 2018 e_1_2_15_1_11_1 e_1_2_15_1_32_1 e_1_2_15_1_53_1 e_1_2_15_1_74_1 e_1_2_15_1_95_1 e_1_2_15_1_15_1 e_1_2_15_1_38_1 e_1_2_15_1_59_1 e_1_2_15_1_13_1 e_1_2_15_1_36_1 e_1_2_15_1_57_1 e_1_2_15_1_19_1 e_1_2_15_1_17_1 e_1_2_15_1_81_1 e_1_2_15_1_40_1 e_1_2_15_1_65_1 e_1_2_15_1_86_1 e_1_2_15_1_67_1 e_1_2_15_1_88_1 e_1_2_15_1_23_1 e_1_2_15_1_44_1 e_1_2_15_1_61_1 e_1_2_15_1_82_1 e_1_2_15_1_21_1 e_1_2_15_1_42_1 e_1_2_15_1_63_1 Remsen L. G. (e_1_2_15_1_78_1) 1996; 17 e_1_2_15_1_84_1 e_1_2_15_1_4_1 e_1_2_15_1_27_1 e_1_2_15_1_48_1 e_1_2_15_1_2_1 e_1_2_15_1_25_1 e_1_2_15_1_46_1 e_1_2_15_1_8_1 e_1_2_15_1_69_1 e_1_2_15_1_6_1 e_1_2_15_1_29_1 e_1_2_15_1_70_1 e_1_2_15_1_91_1 e_1_2_15_1_52_1 e_1_2_15_1_75_1 e_1_2_15_1_50_1 e_1_2_15_1_77_1 e_1_2_15_1_10_1 e_1_2_15_1_33_1 e_1_2_15_1_56_1 e_1_2_15_1_71_1 e_1_2_15_1_94_1 e_1_2_15_1_12_1 e_1_2_15_1_54_1 e_1_2_15_1_73_1 e_1_2_15_1_96_1 e_1_2_15_1_37_1 e_1_2_15_1_16_1 e_1_2_15_1_35_1 e_1_2_15_1_58_1 e_1_2_15_1_14_1 e_1_2_15_1_18_1 e_1_2_15_1_39_1 Rupp R. (e_1_2_15_1_79_1) 2007; 2 e_1_2_15_1_80_1 e_1_2_15_1_41_1 e_1_2_15_1_64_1 e_1_2_15_1_87_1 e_1_2_15_1_66_1 e_1_2_15_1_89_1 e_1_2_15_1_22_1 e_1_2_15_1_45_1 e_1_2_15_1_60_1 e_1_2_15_1_83_1 e_1_2_15_1_20_1 e_1_2_15_1_43_1 e_1_2_15_1_62_1 e_1_2_15_1_85_1 e_1_2_15_1_26_1 e_1_2_15_1_49_1 e_1_2_15_1_5_1 e_1_2_15_1_24_1 e_1_2_15_1_47_1 e_1_2_15_1_3_1 e_1_2_15_1_9_1 e_1_2_15_1_68_1 e_1_2_15_1_7_1 e_1_2_15_1_28_1 e_1_2_15_1_90_1 e_1_2_15_1_92_1 |
| References_xml | – ident: e_1_2_15_1_58_1 doi: 10.2174/1389557517666170512095151 – ident: e_1_2_15_1_45_1 doi: 10.2174/138920012798356899 – ident: e_1_2_15_1_80_1 doi: 10.1038/s41392‐017‐0004‐3 – ident: e_1_2_15_1_23_1 doi: 10.1002/cmmi.420 – ident: e_1_2_15_1_28_1 doi: 10.1016/j.copbio.2004.11.003 – ident: e_1_2_15_1_9_1 doi: 10.3390/pharmaceutics9020012 – ident: e_1_2_15_1_69_1 doi: 10.1039/C6TB01095D – ident: e_1_2_15_1_82_1 doi: 10.1016/j.ijpharm.2004.12.010 – ident: e_1_2_15_1_61_1 doi: 10.1038/nmat1390 – ident: e_1_2_15_1_12_1 doi: 10.1039/c7nr07450f – ident: e_1_2_15_1_15_1 doi: 10.3390/molecules23040938 – ident: e_1_2_15_1_96_1 doi: 10.3389/fphar.2017.00374 – ident: e_1_2_15_1_26_1 doi: 10.1007/s10856‐009‐3807‐0 – ident: e_1_2_15_1_68_1 doi: 10.1038/clpt.2008.296 – ident: e_1_2_15_1_3_1 doi: 10.1021/acs.jafc.8b01052 – ident: e_1_2_15_1_85_1 doi: 10.1016/j.yexmp.2008.12.004 – ident: e_1_2_15_1_6_1 doi: 10.1126/science.1242477 – ident: e_1_2_15_1_87_1 doi: 10.1056/nejm200103153441101 – ident: e_1_2_15_1_8_1 doi: 10.1055/s-1978-24702 – ident: e_1_2_15_1_49_1 doi: 10.5402/2012/571394 – ident: e_1_2_15_1_55_1 doi: 10.4103/0975‐7406.130965 – ident: e_1_2_15_1_39_1 doi: 10.3389/fphar.2018.00790 – ident: e_1_2_15_1_62_1 doi: 10.2217/nnm.12.185 – ident: e_1_2_15_1_53_1 doi: 10.1016/j.bbamem.2009.06.022 – ident: e_1_2_15_1_63_1 doi: 10.1038/nbt1003 – ident: e_1_2_15_1_75_1 doi: 10.15226/2374‐6866/1/2/00109 – ident: e_1_2_15_1_54_1 doi: 10.1038/nbt929 – ident: e_1_2_15_1_42_1 doi: 10.1007/s11060‐005‐9059‐z – ident: e_1_2_15_1_32_1 doi: 10.1177/117739280700200002 – ident: e_1_2_15_1_60_1 doi: 10.1007/978‐1‐60327‐198‐1_1 – ident: e_1_2_15_1_33_1 doi: 10.1007/978-0-387-30428-1_15 – ident: e_1_2_15_1_57_1 doi: 10.1021/mp1001944 – ident: e_1_2_15_1_7_1 doi: 10.2174/1389200217666160619191853 – ident: e_1_2_15_1_16_1 doi: 10.1016/j.drudis.2011.10.028 – ident: e_1_2_15_1_91_1 doi: 10.1007/s00430‐009‐0116‐7 – ident: e_1_2_15_1_18_1 doi: 10.2147/IJN.S596 – volume-title: Nanostructures for the engineering of cells, tissues and organs: From design to applications year: 2018 ident: e_1_2_15_1_31_1 – ident: e_1_2_15_1_52_1 doi: 10.1517/17425247.2014.924501 – ident: e_1_2_15_1_11_1 doi: 10.1016/j.nano.2014.11.003 – ident: e_1_2_15_1_72_1 doi: 10.1038/nbt0202‐155 – ident: e_1_2_15_1_4_1 doi: 10.2741/e102 – ident: e_1_2_15_1_27_1 doi: 10.1016/j.nbd.2009.07.028 – volume: 17 start-page: 411 issue: 3 year: 1996 ident: e_1_2_15_1_78_1 article-title: MR of carcinoma‐specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis publication-title: AJNR. American Journal of Neuroradiology – ident: e_1_2_15_1_95_1 doi: 10.1038/nm1101‐1241 – ident: e_1_2_15_1_74_1 doi: 10.1038/nrd2591 – ident: e_1_2_15_1_84_1 doi: 10.1016/j.ijpharm.2018.12.080 – ident: e_1_2_15_1_35_1 doi: 10.1289/ehp.8284 – ident: e_1_2_15_1_46_1 doi: 10.1016/j.arabjc.2017.05.011 – ident: e_1_2_15_1_66_1 doi: 10.1146/annurev.bioeng.9.060906.152025 – ident: e_1_2_15_1_48_1 doi: 10.1016/S1369‐7021(10)70142‐5 – ident: e_1_2_15_1_65_1 doi: 10.2147/ijn.s129300 – ident: e_1_2_15_1_17_1 doi: 10.1016/j.nantod.2016.07.002 – ident: e_1_2_15_1_88_1 doi: 10.4103/2230‐973x.96920 – ident: e_1_2_15_1_93_1 doi: 10.1016/j.ijpharm.2018.10.011 – ident: e_1_2_15_1_13_1 doi: 10.1016/j.tibtech.2016.08.011 – ident: e_1_2_15_1_30_1 doi: 10.3390/ma3021420 – ident: e_1_2_15_1_10_1 doi: 10.1021/acs.biomac.6b01604 – ident: e_1_2_15_1_41_1 doi: 10.1016/j.ijbiomac.2016.12.055 – ident: e_1_2_15_1_94_1 doi: 10.1208/s12249‐014‐0113‐z – volume: 2 start-page: 367 issue: 4 year: 2011 ident: e_1_2_15_1_51_1 article-title: Superparamagnetic iron oxide nanoparticles: Promises for diagnosis and treatment of cancer publication-title: International Journal of Molecular Epidemiology and Genetics – ident: e_1_2_15_1_76_1 doi: 10.1021/nl8029114 – ident: e_1_2_15_1_19_1 doi: 10.1021/ac034672u – ident: e_1_2_15_1_67_1 doi: 10.1093/annonc/mdh097 – ident: e_1_2_15_1_29_1 doi: 10.1038/nmeth791 – ident: e_1_2_15_1_81_1 doi: 10.3390/app8020172 – ident: e_1_2_15_1_71_1 doi: 10.1021/nn900761s – ident: e_1_2_15_1_22_1 doi: 10.1021/nn900002m – ident: e_1_2_15_1_37_1 doi: 10.1016/j.jconrel.2015.10.006 – ident: e_1_2_15_1_92_1 doi: 10.1038/nbt764 – ident: e_1_2_15_1_25_1 doi: 10.1021/nn101427t – ident: e_1_2_15_1_50_1 doi: 10.1021/cm2031569 – ident: e_1_2_15_1_59_1 doi: 10.1038/sj.bjc.6602204 – ident: e_1_2_15_1_77_1 doi: 10.1158/1078‐0432.ccr‐06‐0946 – ident: e_1_2_15_1_83_1 doi: 10.1038/nrc.2016.108 – ident: e_1_2_15_1_64_1 doi: 10.4103/0250‐474x.57282 – ident: e_1_2_15_1_47_1 doi: 10.17795/ijcp‐3966 – ident: e_1_2_15_1_40_1 doi: 10.1002/wnan.72 – ident: e_1_2_15_1_21_1 doi: 10.1016/j.bjbas.2017.03.004 – ident: e_1_2_15_1_34_1 doi: 10.1158/0008‐5472.can‐10‐1022 – ident: e_1_2_15_1_97_1 doi: 10.2147/ijn.s111594 – ident: e_1_2_15_1_20_1 doi: 10.1016/s0140‐6736(05)66544‐0 – ident: e_1_2_15_1_70_1 doi: 10.1186/bcr432 – ident: e_1_2_15_1_14_1 doi: 10.1021/acsami.8b04962 – ident: e_1_2_15_1_38_1 doi: 10.1002/1097-0142(20010501)91:9<1826::AID-CNCR1203>3.0.CO;2-J – ident: e_1_2_15_1_43_1 doi: 10.1002/anie.200905126 – ident: e_1_2_15_1_36_1 doi: 10.1021/acsbiomaterials.7b00181 – ident: e_1_2_15_1_73_1 doi: 10.1140/epje/i2016‐16059‐8 – ident: e_1_2_15_1_2_1 doi: 10.1080/1061186x.2018.1527337 – ident: e_1_2_15_1_90_1 doi: 10.2147/ijn.s46900 – ident: e_1_2_15_1_56_1 doi: 10.1007/s11060‐006‐9195‐0 – ident: e_1_2_15_1_24_1 doi: 10.1039/b107318b – ident: e_1_2_15_1_44_1 doi: 10.2174/1389200217666160728152939 – ident: e_1_2_15_1_86_1 doi: 10.3389/fmolb.2017.00052 – volume: 2 start-page: 561 issue: 4 year: 2007 ident: e_1_2_15_1_79_1 article-title: VivaGel (SPL7013 Gel): A candidate dendrimer–microbicide for the prevention of HIV and HSV infection publication-title: International Journal of Nanomedicine – ident: e_1_2_15_1_89_1 doi: 10.1200/jco.2002.20.3.719 – ident: e_1_2_15_1_5_1 doi: 10.1200/jco.2001.19.5.1444 |
| SSID | ssj0009933 |
| Score | 2.6758823 |
| SecondaryResourceType | review_article |
| Snippet | Rapid growth in nanotechnology toward the development of nanomedicine agents holds massive promise to improve therapeutic approaches against cancer.... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1962 |
| SubjectTerms | Cancer Cancer therapies cancer therapy Contrast agents Drug carriers Drug Carriers - chemistry Drug delivery Drug delivery systems Drug Delivery Systems - methods Gene transfer Glycan Humans Lipids Nanomaterials Nanomedicine - methods Nanoparticles Nanoparticles - chemistry Nanotechnology Neoplasms - drug therapy Polymers Polymers - chemistry Therapeutic applications therapeutics Therapy Tumors |
| Title | Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.29126 https://www.ncbi.nlm.nih.gov/pubmed/31441032 https://www.proquest.com/docview/2321380681 https://www.proquest.com/docview/2322732352 |
| Volume | 235 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZaxsxEB5MINCXpIlzuE2DWkLxyzqrYw-1T8Y0BENLKDX4IbDoWkjTro2PB_fXV8fuuk5bKH1b0EjalTTab6SZbwCumHDZXzWPcKJJxDKWRJwlPGKCCBMnRArqApw_fkpvJ2w8TaYdeN_EwgR-iPbAzWmG36-dggu5vN6Shn5V8wHhmDi6beer5QDR5y11FK_TyHsXhIThhlUoJtdtzd1_0W8Acxev-h_OzSHcN68a_EweB-uVHKgfT1gc__NbnsNBDUTRMKycI-iY6hi6w8oa4d836C3yrqH-zP0Y9kPGyk0XHu1ubM3s2psOiUoj5dbNAoVArs07dLcN31wiC4nRL3fkaFaiaqeFh8rVRK2_u5MILS5PYHLz4cvoNqrzNUSKWUWOUq4ZN6kpBY-FUlIS7U5ZqcJaMYFVmacyF7mUkurYOGMKS2EHwAijrB2q6SnsVbPKnAPSklq7UcXUpKU14RIpsMzKjEuZCUpU3oN-M3OFqsnMXU6Nb0WgYSaFHdLCD2kP3rSi88Dg8Sehi2b6i1qJl4UFm5jmcZrjHrxui636uTsVUZnZ2stYAEgsjO3BWVg2bS_UGasxtSV9P_l_774Yj-78w4t_F30Jz4iz_b0_3AXsrRZr88oCpJW89JrwE410DLI |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIgQXoC3QhQIGAeol2_iRbFyph6ql2j5VoVbqLfgVqQ-SVXdXaPlN_BX-E34kWZaH1EsP3CJlYkf2jP3NePwNwDsmXPVXzSOcaBKxHksizhIeMUGEiRMiBXUXnA-P0v4p2ztLzubge3MXJvBDtAE3Zxl-vXYG7gLSa1PW0As16BKOSVqnVO6byVfrsA03drft7L4nZOfjyVY_qmsKRIpZZYtSrhk3qSkEj4VSUhLtIoFUYa2YwKrIUpmJTEpJdWwc4MdS2P6MMMr6Spradu_AXVdB3DH1b3-aklXxunC9T3pIGG54jGKy1v7q7O73B6SdRch-i9t5BD-awQmZLZfd8Uh21bffeCP_l9F7DA9rrI02g3EswJwpF2FpsxSj6ssEfUA--9UfKyzCvVCUc7IEl3bDqQZNwiASpUbKmcY1CnfVJuvoeHpDdYgs6ke_pAGgqkDlTAvnpfsStSn9TiK0OHwCp7cyAE9hvqxKswxIS2pdYxVTkxbWS02kwLJX9LiUPUGJyjqw2qhKrmq-dlc25CoPTNMkt1OY-ynswNtWdBBISv4mtNLoW16vU8Pc4mlMszjNcAfetK_tCuOOjURpqrGXsRiXWKTegWdBT9teqPPHY2rfrHpt-3f3-d7WsX94fnPR13C_f3J4kB_sHu2_gAfEhTp8-t8KzI-ux-alxYMj-cqbIYLPt625PwGOM23f |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwEB6VIhAvHC3QhQIGAepLtvGRbIzEQ9Vl1QOqFaJS31JfkeiRrLq7qrZ_ib_Cj8JHkmU5JF76wFukTOzInrG_sWe-AXjNhKv-qnmEE00i1mNJxFnCIyaIMHFCpKAuwfnTQbpzyPaOkqMl-NbkwgR-iPbAzVmGX6-dgY90sTknDT1Roy7hmKR1ROW-mV1af238frdvJ_cNIYMPX7Z3orqkQKSY1bUo5Zpxk5pC8FgoJSXR7iCQKqwVE1gVWSozkUkpqY6Nw_tYCtufEUZZV0lT2-4NuMnSmLs6Ef3Pc64qXtet9zEPCcMNjVFMNttfXdz8fkO0iwDZ73CDe_C9GZsQ2HLanU5kV139Qhv5nwzefbhbI220FUzjASyZcgVWt0oxqc5n6C3ysa_-UmEFboWSnLNVOLXbTTVqwgWRKDVSzjAuUMhUm71Dw3l-6hhZzI9-CgJAVYHKhRa-lu5L1Ab0O4nQ4vghHF7LADyC5bIqzRogLal1jFVMTVpYHzWRAste0eNS9gQlKuvARqMpuarZ2l3RkLM88EyT3E5h7qewA69a0VGgKPmT0Hqjbnm9So1zi6YxzeI0wx142b6264u7NBKlqaZexiJcYnF6Bx4HNW17oc4bj6l9s-GV7e_d53vbQ__w5N9FX8DtYX-Qf9w92H8Kd4g75_Cxf-uwPLmYmmcWDE7kc2-ECI6vW3F_AM9wbI4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanoparticles+and+cancer+therapy%3A+Perspectives+for+application+of+nanoparticles+in+the+treatment+of+cancers&rft.jtitle=Journal+of+cellular+physiology&rft.au=Aghebati-Maleki%2C+Ali&rft.au=Dolati%2C+Sanam&rft.au=Ahmadi%2C+Majid&rft.au=Baghbanzhadeh%2C+Amir&rft.date=2020-03-01&rft.eissn=1097-4652&rft.volume=235&rft.issue=3&rft.spage=1962&rft_id=info:doi/10.1002%2Fjcp.29126&rft_id=info%3Apmid%2F31441032&rft.externalDocID=31441032 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon |